EASD 2018: InTandem 1 Shows Promise for Adjunctive Therapy in Type 1 Diabetes
Sotagliflozin helps patients achieve glycemic targets, lose weight, and improve blood pressure control
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.